• Home
  • Products
    • Human Bio-Materials
      • Human Blood Products
      • Tissues & Specialities
      • Controls, Pools & Standards
    • Services
      • Enhanced Biobanking
      • IVD Development
      • ICS – in.vent Clinical Services
      • Donation Center
      • Preanalytics
      • Storage & Delivery
      • Biomarker Development and Antibody Validation
  • News
  • Company
    • Cooperations
    • Trade shows
  • Contact
  • Home
  • Products
    • Human Bio-Materials
      • Human Blood Products
      • Tissues & Specialities
      • Controls, Pools & Standards
    • Services
      • Enhanced Biobanking
      • IVD Development
      • ICS – in.vent Clinical Services
      • Donation Center
      • Preanalytics
      • Storage & Delivery
      • Biomarker Development and Antibody Validation
  • News
  • Company
    • Cooperations
    • Trade shows
  • Contact
  • De
  • En
  • De
  • En

Archives: News

Happy New Year 2020

Review of the year 2019

Obesity Panel

Rheumatic Diseases

Autoimmunity

Thyroid Diseases

Allergy Bulks & Panels

Procalcitonin (PCT) Panels

Procalcitonin (PCT) Panels

Gerontology Panel

Blood Products

Collection of Autoimmune Diseases

Collection of Autoimmune Diseases

Posts pagination

Previous page Page 1 … Page 20 Page 21

Search

Recent Comments

    Archives

    Categories

    • Geschäftsführung
    • Marketing und Vertrieb

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Location

    Neuendorfstraße 17
    D-16761 Hennigsdorf bei Berlin

    Main office: +49 (0) 3302 55199-0
    FAX: +49 (0) 3302 55199-999

    E-mail: info@inventdiagnostica.de

    LinkedIn
    MDC-Plakette

    Subscribe to Newsletter

    Sign in

    © 2019

    • in.vent Diagnostica GmbH
    • Imprint
    • Privacy Policy
    • General Terms and Conditions of Sale and Delivery
    • in.vent Diagnostica GmbH
    • Imprint
    • Privacy Policy
    • General Terms and Conditions of Sale and Delivery

    ES IST EIN INNOVATIONSASSISTENT ÜBER DEN EUROPÄISCHEN SOZIALFOND FÜR DEN AUFBAU FOLGENDER INNOVATION BESCHÄFTIGT:

    • Die betriebliche Innovation soll zur Entwicklung von neuartigen Produkten, Standardmaterialien und Standard-Services (PMS) für den proaktiven Vertrieb am diagnostischen Weltmarkt führen. Produkte und Standardmaterialien werden in die firmeneigene Website und das interne digitale Projektmanagement-Betriebssystem (CRM) implementiert“
    • Ziel ist es, die Entwicklung und Etablierung dieser Produkte und die Etablierung dieses Prozesses im Allgemeinen innerhalb von zwei Jahren abzuschließen. Der Prozess muss dynamisch reproduzierbar sein. Bestehende PMS bedürfen des regelmäßigen Monitorings.
    Qualification measures:

    Growing Organisation; Adaption of Qualification to new market demands, project areas and fields of production

    To achieve the goal, that invent persist at the international market, qualification for current and new employees were conducted as follows:

    • training in online-marketing,
    • in contract law and
    • in business basics for executive leadership with scientific background.

    New employees acquired competences in the fields of:

    • data protection,
    • medical devices advice,
    • internal auditing,
    • performance assessment of in-vitro diagnostics as well as
    • project management

    In the field of production, knowledge of macro programming was gained for digitization.

    The measures were funded through the European Social Fund and the state of Brandenburg for the period 2019 – 2021.